Another year, another set of blockbuster year-end results from the three most talked about companies in psychedelics. Mind Medicine (MNMD), Compass Pathways (CMPS), and atai Life Sciences (ATAI) have all greatly benefited from 2021’s banner year. With a handful of successful funding rounds, strategic partnerships, and their continuous push for drug development, the “Big 3”…

You must have PRO to access this content.